47 results on '"DiMichele, D. M."'
Search Results
2. Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction
3. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study
4. Design of clinical trials for new products in hemophilia: communication from the SSC of the ISTH
5. Use of global assays to understand clinical phenotype in congenital factor VII deficiency
6. Clinical trial design in haemophilia
7. Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease
8. Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven®, a factor XI concentrate
9. Immune tolerance induction in hemophilia: evidence and the way forward: SA-TH-001
10. Session M1.1 International prospective randomized immune tolerance (ITI) study: preliminary results of therapeutic efficacy and safety: 07S03
11. Hereditary warfarin resistance in 16 patients due to nine novel and three known VKORC1 mutations: OC-WE-077
12. Power Doppler sonography in the diagnosis of hemophilic synovitis - a promising tool
13. Rare inherited disorders of fibrinogen
14. Ethical considerations in clinical investigation: exploring relevance in haemophilia research
15. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile
16. International workshop on immune tolerance induction: consensus recommendations
17. Immune tolerance: critical issues of factor dose, purity and treatment complications
18. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis
19. The international immune tolerance study: a multicenter prospective randomized trial in progress
20. International immune tolerance (ITI) study: frequency of central venous line infection and effect on ITI outcome: 14 PO 379
21. Haemophilia Inhibitor Genetics Study – evaluation of a model for studies of complex diseases using linkage and association methods
22. Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias
23. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection
24. Long-term FEIBA prophylaxis does not prevent progression of existing joint disease
25. Inhibitors: resolving diagnostic and therapeutic dilemmas
26. Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experience
27. Continuous infusion of porcine factor VIII in patients with haemophilia A and high-responding inhibitors: stability and clinical experience
28. CONTINUOUS INFUSION OF PORCINE FVIII IN PATIENTS WITH HAEMOPHILIA A AND INHIBITORS.
29. Thrombin generation and bleeding in haemophilia inhibitor patients during immune tolerance induction
30. Various Missense Mutations in the Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1) Cause Hereditary Coumarin Resistance
31. Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease
32. The potential role of power Doppler ultrasound in the diagnosis of haemophilic arthropathy
33. Continuous infusion of porcine factor VIII in patients with haemophilia A and high-responding inhibitors: stability and clinical experience
34. Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia a patients with inhibitors
35. Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven®, a factor XI concentrate.
36. The North American Immune Tolerance Registry: Practices, Outcomes, Outcome Predictors
37. 901 ACQUIRED VON WILLEBRAND'S DISEASE (vWD) SECONDARY TO SPLENIC HEMANGIOMA
38. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study.
39. Continuous infusion of porcine factor VIII: stability, microbiological safety and clinical experience.
40. Inhibitors in haemophilia: a primer.
41. Analysis of the North American Immune Tolerance Registry (NAITR) 1993-1997: current practice implications. ISTH Factor VIII/IX Subcommittee Members.
42. Inhibitors occur more frequently in African-American and Latino haemophiliacs.
43. Heparin and the risk of intraventricular hemorrhage in premature infants.
44. Management of an acute hemorrhagic ovarian cyst in a female patient with hemophilia A.
45. In vitro factor VIII recovery during the delivery of ultrapure factor VIII concentrate by continuous infusion.
46. Use of DDAVP in inherited and acquired platelet dysfunction.
47. Collagen-binding of von Willebrand's factor antigen in the classification of von Willebrand's disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.